IFNG and neoplasm: Our ELISPOT data elucidated that the IFN-γ secreting spot forming within the DC/tumor fusion+ LPS-RGD-Nb36-DOX categories were elevated compared with those within the other control group after being challenged with Hep3B and A-427 cells (Fig. 3A).